Market Research Logo

Diabetic Neuropathy Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023

Diabetic Neuropathy Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023

The report on global Diabetic Neuropathy market provides qualitative and quantitative analysis for the period of 2017 to 2023. The report predicts the global Diabetic Neuropathy market to grow with a CAGR between 5.0 % and 5.5 % from 2017 to 2023. The global Diabetic Neuropathy market was worth 3.58 Bn in 2016.The study on Diabetic Neuropathy market covers the analysis of regions such as North America, Europe, Asia Pacific, and Rest of the World. Among the geographies North America dominated the world market and Asia Pacific anticipated growing at the highest CAGR over the forecast period.

The report on global Diabetic Neuropathy market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global Diabetic Neuropathy market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that driving, restraining the global Diabetic Neuropathy market. Porter’s five forces model in the report provides insights into the competitive rivalry in the global Diabetic Neuropathy market over the period of 2017 – 2023. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research methodology
• Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

• Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include
• Company reports and publications
• Government/institutional publications
• Trade and associations’ journals
• Databases such as WTO, OECD, and Worldbank, among others.
• Websites and publications by research agencies

Report Findings
1) Drivers
• Increasing diabetic population across the globe along with growing awareness among people.
• Changing lifestyle that results in to unhealthy dietary habits and patterns
• Increased healthcare expenditure for diabetes
2) Restraints
• Longer approval time for drugs.
• High cost and side effects of diabetic neuropathy treatment.
3) Opportunities
• Increasing rate of Diabetes
• Increasing Research and Development activities

Segments Covered
1) Global Diabetic Neuropathy market by product type
a. By Disorder Type
• Peripheral Neuropathy
• Autonomic Neuropathy
• Proximal Neuropathy
• Focal Neuropathy

b. By Treatment Type
• Drug
Analgesics
Antidepressant
Anticonvulsants

• Radiotherapy
• Physiotherapy
c. By Distribution Channel
• Hospitals
• Clinics
• Retail Pharmacy
• Online Pharmacy

2) Global Diabetic Neuropathy market by Region
a. North America
b. Europe
c. Asia Pacific
d. Row

Companies Profiled:
The companies covered in the report include
• Pfizer Inc
• Janssen Pharmaceuticals, Inc
• Eli Lilly and Company
• ACTAVIS
• Cephalon Inc
• MEDA Pharma GmBH & Co. KG
• GlaxoSmithKline
• Johnson and Johnson.

Reasons to buy this report
1) Comprehensive analysis of global as well as regional markets of Diabetic Neuropathy.
2) Complete coverage of all the product type and applications segments to analyze the trends, developments in Diabetic Neuropathy market, and forecast of market size up to 2023.
3) Comprehensive analysis of the companies operating in Diabetic Neuropathy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4) Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Diabetic Neuropathy Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.2.4 Challenges
3.3 Porter’s Five Forces Analysis
3.4 IGR – Growth Matrix Analysis
3.5 Competitive Landscape in the Diabetic Neuropathy Market
4. Global Diabetic Neuropathy Market : IGR Snapshots
4.1 Global Diabetic Neuropathy Market key trends
4.2 Global Diabetic Neuropathy Market by Disorder Type
4.3 Global Diabetic Neuropathy Market by Treatment Type
4.4 Global Diabetic Neuropathy Market by Distribution channel
4.5 Global Diabetic Neuropathy Market by Region
5. Global Diabetic Neuropathy by Disorder Type (USD Billion) 2017 – 2023
5.1 Peripheral Neuropathy
5.2 Autonomic Neuropathy
5.3 Proximal Neuropathy
5.4 Focal Neuropathy
6. Global Diabetic Neuropathy Market Analysis, by Treatment Type(USD Billion) 2017 – 2023
6.1 Drugs
6.1.1 Analgesics
6.1.1.1 Topical
6.1.1.2 Opioids
6.1.1.3 NSAIDs
6.1.2 Antidepressant
6.1.2.1 TCAs
6.1.2.2 SNRIs
6.1.2.3 SSRIs
6.1.3 Anticonvulsants
6.1.3.1 Pregabalin
6.1.3.2 Topimarate
6.1.3.3 Gabapentin
6.1.3.4 Others
6.2 Radiotherapy
6.2.1 TENS
6.2.2 Other
6.3 Physiotherapy
7. Global Diabetic Neuropathy Market Analysis, by Distribution channel (USD Billion) 2017 – 2023
7.1 Hospitals
7.2 Clinics
7.3 Retail Pharmacy
7.4 Online Pharmacy
8. Global Diabetic Neuropathy Market Analysis, by Region (USD Billion) 2017 – 2023
8.1 North America
8.1.1 North America Diabetic Neuropathy Market by Disorder Type (USD Billion
8.1.2 North America Diabetic Neuropathy Market by Treatment Type (USD Billion)
8.1.3 North America Diabetic Neuropathy Market by Distribution Channel (USD Billion)
8.1.4 North America Diabetic Neuropathy Market by country (USD Billion)
8.2 Europe
8.2.1 Europe Diabetic Neuropathy Market by Disorder Type (USD Billion)
8.2.2 Europe Diabetic Neuropathy Market by Treatment Type (USD Billion)
8.2.3 Europe Diabetic Neuropathy Market by Distribution Channel (USD Billion)
8.2.4 Europe Diabetic Neuropathy Market by Country (USD Billion)
8.3 Asia Pacific
8.3.1 Asia Pacific Diabetic Neuropathy Market by Disorder Type (USD Billion)
8.3.2 Asia Pacific Diabetic Neuropathy Market by Treatment Type (USD Billion)
8.3.3 Asia Pacific Diabetic Neuropathy Market by Distribution Channel (USD Billion)
8.3.4 Asia Pacific Diabetic Neuropathy Market by Country (USD Billion)
8.4 RoW
8.4.1 RoW Diabetic Neuropathy Market by Disorder Type (USD Billion
8.4.2 RoW Diabetic Neuropathy Market by Treatment Type (USD Billion)
8.4.3 RoW Diabetic Neuropathy Market by Distribution Channel (USD Billion)
8.4.4 RoW Diabetic Neuropathy Market by Country (USD Billion)
9. Company Profiles
9.1 Pfizer Inc
9.2 Janssen Pharmaceuticals, Inc
9.3 Eli Lilly and Company
9.4 ACTAVIS
9.5 Cephalon Inc
9.6 MEDA Pharma GmBH & Co. KG
9.7 GlaxoSmithKline
9.8 Johnson and Johnson.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report